🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Voice Worries

However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts said the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the service has taken down problematic material and banned related hashtags and search suggestions. The company stated it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of members, populated with images of weight loss, glowing reviews and detailed guides for preparing or administering at home.

Within moments of joining one community, a vendor posted contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, health issues or previous experience.

Product Information and Costs

Inside these communities, messages display black plastic parcels with postal service stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Although the research behind this drug is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious medical dangers”.